Skip to content

    Sagility Limited

    SAGILITYGood
    Information Technology·27 Nov 2024
    Management Summary

    Sagility India delivered a strong performance in its first earnings call as a listed entity, characterized by 21.1% YoY revenue growth and industry-leading margins. The company is successfully leveraging its deep domain expertise in the U.S. Healthcare market, particularly within the Payer segment. Management is focused on a dual strategy of mining existing large accounts while aggressively targeting the mid-market to diversify its client base and reduce concentration.

    Highlights

    7

    • Revenue reached ₹1,325 crores ($157.9 million) in Q2, representing 21.1% YoY growth in INR terms.

    • Adjusted EBITDA margin stood at a robust 25.5% for the quarter.

    • Consolidated adjusted PAT grew 30.5% YoY to ₹163.6 crores.

    • Headcount increased to 38,380 with 2,522 net additions during the quarter.

    • Payer vertical remains the primary driver, contributing 89.2% of total revenue.

    • Net debt (excluding lease liabilities) reduced to 0.34x of trailing 12-month EBITDA.

    • Annualized attrition remained stable and healthy at 25.8%.

    Concerns

    1

    • High Client Concentration

    Key financials

    Single quarter

    06 metrics
    1. 01Revenue₹1,325 Cr+21.1%YoY
    2. 02Adjusted EBITDA Margin25.5%
    3. 03Adjusted PAT₹163.6 Cr+30.5%YoY
    4. 04Revenue (USD)157.9 Mn
    5. 05Attrition Rate25.8%

    Segment breakdown

    Revenue ShareYoY Growth
    Payer Vertical89.2%20.8%
    Provider Vertical10.8%23.7%
    Heatmap· 2 shared metrics

    Guidance & targets

    5
    CategoryTargetPriority
    Revenue
    Full Year Revenue Growth
    In line with H1 performance (~13.8% CC)
    		High
    Margin
    Adjusted EBITDA Margin
    Steady at current levels (~25.5%)
    		High
    Other
    New Client Additions
    8-12
    		Medium
    Other
    Top 5 Client Concentration
    60-65%
    		Medium
    Debt
    Debt Repayment
    ₹249 crores
    		High

    Risks & concerns

    3
    RiskSeverity

    High Client Concentration

    Top 5 clients contribute 80% of revenue; management is targeting mid-market expansion to reduce this to 60-65% over 2-3 years. — Both acknowledged

    high

    Business Seasonality

    Open enrollment (AEPS) in Q3/Q4 makes the second half of the year more pronounced, making YoY comparisons more relevant than QoQ. — Management acknowledged

    medium

    Captive Center Proliferation

    Analysts raised concerns about clients setting up India captives; management noted they often help clients set up these centers for innovation while retaining core operations. — Analyst downplayed

    medium

    Q&A highlights

    3

    “For our top client, we probably only do, roughly about 80% of the service portfolio that I've shown... so there is still opportunity for us to work with each of these clients in areas which we are not supporting them today on.”

    Clarifies that even within highly concentrated accounts, there is significant 'white space' for organic growth through new service lines like clinical services.

    asked by Abhishek Kumar, JM Financial

    2 min read5 chapters

    Detailed Narrative

    01

    Robust Revenue Momentum in U.S. Healthcare

    Sagility reported a strong 21.1% YoY revenue growth in INR terms for Q2 FY25, reaching ₹1,325 crores. This growth was driven by sustained demand from existing large Payer clients and new logo wins. The Payer vertical continues to dominate the mix at 89.2%, growing 20.8% YoY, while the Provider vertical showed even faster growth at 23.7% YoY, albeit from a smaller base.

    02

    Industry-Leading Margin Resilience

    The company maintained an adjusted EBITDA margin of 25.5% in Q2, consistent with its historical 24-25% range. Management attributed this to high offshoring levels (94% of headcount in nearshore/offshore locations) and continuous operational efficiency gains. They expressed confidence in keeping margins steady at these levels for the remainder of FY25 despite ongoing investments in technology.

    03

    Strategic Pivot to Mid-Market Diversification

    To address high client concentration (Top 5 at 80%), Sagility is aggressively targeting the mid-market and small Payer segments. Management aims to add 8-12 new clients annually and reduce top-5 concentration to 60-65% within the next 2-3 years. They noted that mid-market clients often offer higher efficiency potential due to less 'red tape' compared to national Payers.

    04

    GenAI Integration and Efficiency Levers

    Following the acquisition of BirchAI, Sagility is running multiple GenAI pilots across front-office and clinical operations. Management views GenAI as a tool to reduce 'speed to proficiency' for new hires and improve clinician efficiency in medical documentation. They estimate that while full automation is capped at 15-20% due to healthcare complexity, the productivity gains will be a significant margin lever.

    05

    Strong Cash Generation and De-leveraging

    The company demonstrated excellent cash flow conversion, with H1 FY25 operating cash flow at 114% of reported EBITDA. This strong liquidity has allowed for consistent debt reduction, with net debt (excluding leases) now at just 0.34x EBITDA. Sagility plans to repay ₹249 crores of debt in FY25 and another ₹235 crores in FY26, further strengthening its balance sheet.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.